Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System.
Eur J Pharm Biopharm
; 144: 68-78, 2019 Nov.
Article
em En
| MEDLINE
| ID: mdl-31493511
Medicated chewing gums represent an orally administered dosage form with promising potential for local and systemic drug delivery. However, compared to other solid oral dosage forms, formulation development and release mechanism of medicated chewing gums are extremely complex, and thus only few products reached the approval for the market so far. Therefore, Quality by Design (QbD) approaches for rational formulation development of medicated chewing gums are needed to utilize their full potential. For chewing gum tablets, which are manufactured by direct compression, QbD approaches derived from tableting processes might be exerted. In this context, the SeDeM-Diagram-Expert-System implements the QbD approach while indicating whether a blend is suitable for direct compression and comprises powder properties, which need to be improved to facilitate the formulation development. Here, we present the successful application of the SeDeM-Diagram-Expert-System to the formulation development of medicated chewing gum tablets manufactured by direct compression. Furthermore, limitations of the SeDeM-System for medicated chewing gum tablets are evaluated and potential modifications of the system are suggested and discussed for future use.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Comprimidos
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article